LivaNova PLC: CMS Maintains Vns Therapy for Dre at Level 5 Apc Under 2025 Medicare Hospital Outpatient Prospective Payment System
LivaNova PLC: 康哲藥業維持Vns療法在2025年醫院門診前瞻性支付系統下的Dre的5級Apc
LivaNova PLC: CMS Maintains Vns Therapy for Dre at Level 5 Apc Under 2025 Medicare Hospital Outpatient Prospective Payment System
LivaNova PLC: 康哲藥業維持Vns療法在2025年醫院門診前瞻性支付系統下的Dre的5級Apc
譯文內容由第三人軟體翻譯。